This patented breakthrough is the first and only technology to treat dying tissue and regenerate nerves — restoring circulation, reversing chronic wounds, and preventing amputations for patients who previously had no options.
BREA, Calif., Sept. 23, 2025 /PRNewswire/ — Rapid Nexus, a California-based med-tech company, has unveiled the first medical device proven to regenerate nerves and reverse chronic wounds — offering a long-awaited solution for millions of patients at risk of limb loss from diabetes, trauma, and vascular disease.
Chronic wounds are one of the most costly, overlooked, and deadly health issues facing diabetic and trauma patients today — and until now, there’s been no way to actually heal them.
While the global wound care market surpasses $22.3 billion , current solutions — from wound vacs to skin grafts and antimicrobial creams — focus only on managing surface symptoms rather than addressing the root cause. As a result, tissue continues to deteriorate, infections deepen, and amputation often becomes the only remaining option. Rapid Nexus’s patented technology is the first to intervene at the source by regenerating nerve-damaged tissue and restoring circulation. It has also been shown to outperform leading antimicrobial products commonly used in diabetic amputation cases, without causing additional damage to surrounding healthy tissue.